Importance of hospital and clinical factors in predicting of 30-day mortality in Takotsubo syndrome: data from the Swedish Coronary Angiography and Angioplasty Registry Show others and affiliations
2023 (English) In: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 44, no Suppl. 2, article id ehad655.1566Article in journal, Meeting abstract (Other academic) Published
Abstract [en]
Background : Takotsubo syndrome (TS) is an acute heart failure condition that presents with symptoms similar to acute myocardial infarction. TS is often triggered by emotional or physical stress and is an important cause of morbidity and mortality but predictors of mortality in TS patients are not well understood. There is a need to identify high-risk patients and tailor treatment accordingly.
Purpose : The purpose of this study was to assess the importance of various clinical factors in predicting 30-day mortality in TS patients using a machine-learning algorithm capable of identifying complex relationships between variables.
Methods : We analyzed data from the nationwide Swedish Coronary Angiography and Angioplasty Registry for all TS patients between 2015-2022. Gradient boosting was used to assess the relative importance of variables in predicting 30-day mortality in TS patients.
Results : Of the 3,180 hospitalized TS patients, 76% were women. The average age was 68.3 ± 11.2 years. The crude all-cause mortality rate was 2.57% at 30 days. The most important variable in predicting 30-day mortality was the hospital where the patient was treated, with a relative importance of 35.5%. This was followed by the clinical presentation for angiography (21.1%), creatinine level (11.9%), Killip class (8.9%), and age at angioplasty (6.5%). Other less important factors included weight, height, and certain medical conditions such as hyperlipidemia, smoking status, and hypertension. Gender and previous stroke history had a low impact on 30-day mortality in TS patients.
Conclusions : The treating hospital was the most important factor in predicting 30-day mortality in TS. Since the level of evidence for recommended treatments of TS is low, our findings highlight the importance of conducting randomized studies in this patient group to improve care.
Place, publisher, year, edition, pages Oxford University Press, 2023. Vol. 44, no Suppl. 2, article id ehad655.1566
National Category
Cardiology and Cardiovascular Disease
Identifiers URN: urn:nbn:se:oru:diva-110886 DOI: 10.1093/eurheartj/ehad655.1566 ISI: 001115619402387 OAI: oai:DiVA.org:oru-110886 DiVA, id: diva2:1835581
Conference Annual Meeting of the European-Society-of-Cardiology (ESC), Amsterdam, Netherlands, August 25-28, 2023
Funder Swedish Heart Lung Foundation Swedish Research Council
Note The Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish state under the agreement between the Swedish government and the county councils (the ALF-agreement)
2024-02-062024-02-062025-02-10 Bibliographically approved